• 1
    Strahl BD,Allis CD. The language of covalent histone modifications. Nature 2000; 403: 415.
  • 2
    van Holde KE. Chromatin. New York: Springer, 1988.
  • 3
    Carrozza MJ,Utley RT,Workman JL,Cote J. The diverse functions of histone acetyltransferase complexes. Trends Genet 2003; 19: 3219.
  • 4
    Eberharter A,Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 2002; 3: 2249.
  • 5
    Gayther SA,Batley SJ,Linger L,Bannister A,Thorpe K,Chin SF,Daigo Y,Russell P,Wilson A,Sowter HM,Delhanty JD,Ponder BA, et al. Mutations truncating the EP300 acetylase in human cancers. Nat Genet 2000; 24: 3003.
  • 6
    Seligson DB,Horvath S,Shi T,Yu H,Tze S,Grunstein M,Kurdistani SK. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435: 12626.
  • 7
    Cress WD,Seto E. Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 2000; 184: 116.
  • 8
    Drummond DC,Noble CO,Kirpotin DB,Guo Z,Scott GK,Benz CC. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu Rev Pharmacol Toxicol 2005; 45: 495528.
  • 9
    Munks RJ,Moore J,O'Neill LP,Turner BM. Histone H4 acetylation in Drosophila. Frequency of acetylation at different sites defined by immunolabelling with site-specific antibodies. FEBS Lett 1991; 284: 2458.
  • 10
    Fraga MF,Ballestar E,Villar-Garea A,Boix-Chornet M,Espada J,Schotta G,Bonaldi T,Haydon C,Ropero S,Petrie K,Iyer NG,Perez-Rosado A, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 2005; 37: 391400.
  • 11
    Mendjan S,Taipale M,Kind J,Holz H,Gebhardt P,Schelder M,Vermeulen M,Buscaino A,Duncan K,Mueller J. Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol Cell 2006; 21: 81123.
  • 12
    Smith ER,Cayrou C,Huang R,Lane WS,Cote J,Lucchesi JC. A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol Cell Biol 2005; 25: 917588.
  • 13
    Taipale M,Rea S,Richter K,Vilar A,Lichter P,Imhof A,Akhtar A. hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol Cell Biol 2005; 25: 6798810.
  • 14
    Gupta A,Sharma GG,Young CS,Agarwal M,Smith ER,Paull TT,Lucchesi JC,Khanna KK,Ludwig T,Pandita TK. Involvement of human MOF in ATM function. Mol Cell Biol 2005; 25: 5292305.
  • 15
    Sykes SM,Mellert HS,Holbert MA,Li K,Marmorstein R,Lane WS,McMahon SB. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006; 24: 84151.
  • 16
    Freier K,Joos S,Flechtenmacher C,Devens F,Benner A,Bosch FX,Lichter P,Hofele C. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 2003; 63: 117982.
  • 17
    Schneeweiss A,Bastert G,Huober J,Wallwiener D,Hamerla R,Lichter P. Neoadjuvant therapy with gemcitabine in breast cancer. Oncology (Williston Park) 2004; 18: 2731.
  • 18
    Schneeweiss A,Schuetz F,Rudlowski C,Hahn M,Lauschner I,Sinn HP,von Fournier D,Sohn C. Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial. Anticancer Drugs 2005; 16: 10238.
  • 19
    Brabletz T,Herrmann K,Jung A,Faller G,Kirchner T. Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 2000; 156: 86570.
  • 20
    Team R. R: A language and environment for statistical computing, 2.0.1. ed. Vienna, Austria: R Foundation for Statistical Computing, 2004.
  • 21
    Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
  • 22
    Thuerigen O,Schneeweiss A,Toedt G,Warnat P,Hahn M,Kramer H,Brors B,Rudlowski C,Benner A,Schuetz F,Tews B,Eils R, et al. Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. J Clin Oncol 2006; 24: 183945.
  • 23
    Mendrzyk F,Radlwimmer B,Joos S,Kokocinski F,Benner A,Stange DE,Neben K,Fiegler H,Carter NP,Reifenberger G,Korshunov A,Lichter P. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol 2005; 23: 885362.
  • 24
    Stange DE,Radlwimmer B,Schubert F,Traub F,Pich A,Toedt G,Mendrzyk F,Lehmann U,Eils R,Kreipe H,Lichter P. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin Cancer Res 2006; 12: 34552.
  • 25
    Giangaspero F,Wellek S,Masuoka J,Gessi M,Kleihues P,Ohgaki H. Stratification of medulloblastoma on the basis of histopathological grading. Acta Neuropathol 2006; 112: 512.
  • 26
    Shogren-Knaak M,Ishii H,Sun JM,Pazin MJ,Davie JR,Peterson CL. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006; 311: 8447.